Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?

被引:57
作者
Jardim, Leticia Lemos [1 ]
Alves Rios, Danyelle Romana [2 ]
Perucci, Luiza Oliveira [3 ]
de Sousa, Lirlandia Pires [3 ]
Gomes, Karina Braga [3 ]
Dusse, Luci Maria S. [3 ]
机构
[1] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Sao Joao Del Rei, Brazil
[3] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, BR-31270901 Belo Horizonte, MG, Brazil
关键词
Preeclampsia; Angiogenesis; VEGF; PlGF; Endoglin; sFlt-1; GROWTH-FACTOR RECEPTOR-1; SOLUBLE ENDOGLIN; TYROSINE KINASE-1; ANTIANGIOGENIC FACTORS; PLACENTAL EXPRESSION; EARLY-PREGNANCY; EARLY-ONSET; PREDICTION; HYPERTENSION; RISK;
D O I
10.1016/j.cca.2015.05.004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Preedampsia (PE) is a multisystem disease characterized by the development of hypertension and proteinuria. Although PE etiology is not fully known, the placenta seems to play a central role in the development of disease. The inadequate placentation process results in a change in angiogenic factors levels, such as vascular endothelial growth factor (VEGF), placental growth factor (PIGF), soluble form of endoglin (s-Eng) and soluble form of vascular endothelial growth factor receptor type 1 (sFlt-1). Objective: The aim of this review was to clarify if the imbalance between pro-angiogenic and anti-angiogenic factors is associated with PE. Conclusion: It is known that inadequate placentation process is the primary mechanism suggested for PE occurrence and angiogenic factors are involved in this process. The state-of-the-art suggests that progress in grasp the imbalance of pro-angiogenic and anti-angiogenic factors is essential for the improvement of knowledge about PE. The development of prospective, longitudinal studies with serial determinations of these factors throughout pregnancy is needed to better assess the relevance of these markers for understanding the etiology, prevention, diagnosis, prognosis and treatment of this challenging disease. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 49 条
  • [21] Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
    Levine, Richard J.
    Lam, Chun
    Qian, Cong
    Yu, Kai F.
    Maynard, Sharon E.
    Sachs, Benjamin P.
    Sibai, Baha M.
    Epstein, Franklin H.
    Romero, Roberto
    Thadhani, Ravi
    Karumanchi, S. Ananth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) : 992 - 1005
  • [22] Circulating angiogenic factors and the risk of preeclampsia
    Levine, RJ
    Maynard, SE
    Qian, C
    Lim, KH
    England, LJ
    Yu, KF
    Schisterman, EF
    Thadhani, R
    Sachs, BP
    Epstein, FH
    Sibai, BM
    Sukhatme, VP
    Karumanchi, SA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) : 672 - 683
  • [23] VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma
    Maharaj, Arindel S. R.
    Walshe, Tony E.
    Saint-Geniez, Magali
    Venkatesha, Shivalingappa
    Maldonado, Angel E.
    Himes, Nathan C.
    Matharu, Kabir S.
    Karumanchi, S. Ananth
    D'Amore, Patricia A.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (02) : 491 - 501
  • [24] Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia
    Maynard, SE
    Min, JY
    Merchan, J
    Lim, KH
    Li, JY
    Mondal, S
    Libermann, TA
    Morgan, LP
    Sellke, FW
    Stillman, IE
    Epstein, FH
    Sukhatme, VP
    Karumanchi, SA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) : 649 - 658
  • [25] Nicotine restores endothelial dysfunction caused by excess sFlt1 and sEng in an in vitro model of preeclamptic vascular endothelium: a possible therapeutic role of nicotinic acetylcholine receptor (nAChR) agonists for preeclampsia
    Mimura, Kazuya
    Tomimatsu, Takuji
    Sharentuya, Namuxila
    Tskitishvili, Ekaterine
    Kinugasa-Taniguchi, Yukiko
    Kanagawa, Takeshi
    Kimura, Tadashi
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (05) : 464.e1 - 464.e6
  • [26] Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia
    Nagamatsu, T
    Fujii, T
    Kusumi, M
    Zou, L
    Yamashita, T
    Osuga, Y
    Momoeda, M
    Kozuma, S
    Taketani, Y
    [J]. ENDOCRINOLOGY, 2004, 145 (11) : 4838 - 4845
  • [27] Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia
    Perucci, Luiza O.
    Gomes, Karina B.
    Freitas, Leticia G.
    Godoi, Lara C.
    Alpoim, Patricia N.
    Pinheiro, Melina B.
    Miranda, Aline S.
    Teixeria, Antonio L.
    Dusse, Luci M.
    Sousa, Lirlandia P.
    [J]. PLOS ONE, 2014, 9 (05):
  • [28] Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia
    Pineles, Beth L.
    Romero, Roberto
    Montenegro, Daniel
    Tarca, Adi L.
    Han, Yu Mi
    Kim, Yeon Mee
    Draghici, Sorin
    Espinoza, Jimmy
    Kusanovic, Juan Pedro
    Mittal, Pooja
    Hassan, Sonia S.
    Kim, Chong Jai
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (03) : 261 - 263
  • [29] D-dimer in preeclampsia: Systematic review and meta-analysis
    Pinheiro, Melina de Barros
    Garcia Junqueira, Daniela Rezende
    Coelho, Fernanda Fonseca
    Freitas, Leticia G.
    Carvalho, Maria G.
    Gomes, Karina Braga
    Santana Dusse, Luci Maria
    [J]. CLINICA CHIMICA ACTA, 2012, 414 : 166 - 170
  • [30] Epigenetics in Women's Health Care
    Pozharny, Yevgeniya
    Lambertini, Luca
    Clunie, Garfield
    Ferrara, Lauren
    Lee, Men-Jean
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (02): : 225 - 235